With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.3030-47-5,N1-(2-(Dimethylamino)ethyl)-N1,N2,N2-trimethylethane-1,2-diamine,as a common compound, the synthetic route is as follows.
The complex [Ni3(pmdien)3(mu-ttc)](ClO4)3, where pmdien = N,N,N?,N??,N??-pentamethyldiethylenetriamine,was prepared according to Kopel et al. [33], by reaction of pmdien (0.2 mL, 1 mmol) withNi(ClO4)2¡¤6H2O (0.37 g, 1 mmol) in EtOH, followed by the addition of a solution of ttcNa3¡¤9H2O(0.14 g, 0.33 mmol). Yield: 72%. Anal. Calcd.: C, 30.8; H, 6.0; N, 14.4; S, 8.2. Found: C, 30.4; H, 5.9;N, 14.1; S, 7.7%.
As the paragraph descriping shows that 3030-47-5 is playing an increasingly important role.
Reference£º
Article; Kopel, Pavel; Wawrzak, Dorota; Langer, Vratislav; Cihalova, Kristyna; Chudobova, Dagmar; Vesely, Radek; Adam, Vojtech; Kizek, Rene; Molecules; vol. 20; 6; (2015); p. 10360 – 10376;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI